Targeting hyperglucagonaemia in T2DM

被引：1
|
作者：
Starling S.
机构：
[1] Nature Reviews Endocrinology,
来源：
Nature Reviews Endocrinology | 2022年 / 18卷 / 7期
关键词：
D O I：
10.1038/s41574-022-00694-3
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：393 / 393
相关论文
共 50 条
  • [41] Shared variants for osteoporosis and T2DM
    Greenhill, Claire
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2018, 14 (11) : 627 - 627
  • [42] SGLT2 blockers in T2DM
    Barranco, Caroline
    [J]. NATURE REVIEWS CARDIOLOGY, 2018, 15 (05) : 255 - 255
  • [43] Why β cells fail in T2DM
    Holmes, David
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (08) : 440 - 440
  • [44] Designing a new therapy for T2DM
    Claire Greenhill
    [J]. Nature Reviews Endocrinology, 2019, 15 : 684 - 684
  • [45] Microbial metabolite linked to T2DM
    Alan Morris
    [J]. Nature Reviews Endocrinology, 2019, 15 : 3 - 3
  • [46] T2DM treatment trial results
    Greenhill, Claire
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (09) : 499 - 499
  • [47] Dietary factors in the risk of T2DM
    Claire Greenhill
    [J]. Nature Reviews Endocrinology, 2020, 16 : 537 - 537
  • [48] Linking nicotine addiction and T2DM
    Morris, Alan
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (01) : 6 - 6
  • [49] SGLT2 blockers in T2DM
    Caroline Barranco
    [J]. Nature Reviews Cardiology, 2018, 15 : 255 - 255
  • [50] T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients
    Thummasorn, Savitree
    Apichai, Sopida
    Chupradit, Supat
    Sirisattayawong, Pornpen
    Chaiwong, Pachpilai
    Sriwichaiin, Sirawit
    Pratchayasakul, Wasana
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    [J]. PLOS ONE, 2022, 17 (08):
12345